BNTX
BIONTECH (BNTX) CEO Ugur Sahin Sells $8.4M in Shares
Two open-market sales on September 11 and 14 cut the founder-CEO's directly held stake to 602,209 ordinary shares.
BNTX
Market-moving news on BioNTech (NASDAQ: BNTX): filings, earnings, deals and other events, from REDFILED.
BNTX
BIONTECH Says Gotistobart Nearly Doubled Survival in Lung Cancer Trial
BioNTech and partner OncoC4 report first median overall survival data from stage 1 of the Phase 3 PRESERVE-003 trial in squamous NSCLC.
BNTX
BIONTECH CEO Ugur Sahin Sells $7.2M in Shares Over Two Days
BioNTech chief executive and 10% owner Ugur Sahin sold 73,000 ordinary shares on 8 and 9 September, leaving him with 708,709 shares in the reported account.